Kynam Capital Management, LP
- SEC CIK
- 0001907884
- Latest filing
- Aug 14, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Kynam Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −784,606−100.0% | Sold out | Holders |
| Q1 2026 | 784,606 | $8.35M | 0.5% | 00.0% | Unchanged | Holders |
| Q4 2025 | 784,606 | $7.36M | 0.5% | −244,973−23.8% | Reduced | Holders |
| Q3 2025 | 1,029,579 | $7.75M | 0.6% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,029,579 | $3.47M | 0.4% | +125,562+13.9% | Added | Holders |
| Q1 2025 | 904,017 | $3.49M | 0.3% | +904,017 | New | Holders |